Pharma quality and supply networks depend on faster access to the right signals across deviations, CAPAs, suppliers, audits, regulatory inputs, and disconnected data. In this session, Rishi Raina will explore how AI can help surface risk earlier, accelerate investigations, strengthen inspection readiness, and scale decision-making with greater confidence.